Seeing Is Believing
VIVO is currently covered by 1 analysts with an average price target of $1.95. This is a potential upside of $1.95 (0%) from yesterday's end of day stock price of $0.
Meridian Bioscience's activity chart (see below) currently has 30 price targets and 22 ratings on display. The stock rating distribution of VIVO is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 81.67% with an average time for these price targets to be met of 356.25 days.
Highest price target for VIVO is $33, Lowest price target is $33, average price target is $1.95.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 08-Jul-2022. First documented stock forecast 04-May-2015.
Currently out of the existing stock ratings of VIVO, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
$-3.97 (-11.69%)
30
1 years 9 months 20 days ago
6/9 (66.67%)
$-3 (-9.09%)
337
Buy
34
$0.03 (0.09%)
34
3 years 2 months 5 days ago
3/5 (60%)
$12.77 (60.15%)
96
Sell
11
4 years 11 months 27 days ago
4/4 (100%)
$-2.29 (-17.23%)
545
Sell
15
$-18.97 (-55.84%)
15
4 years 11 months 27 days ago
4/4 (100%)
$0.32 (2.35%)
447
What is VIVO (Meridian Bioscience) average time for price targets to be met?
Which analyst has the current highest performing score on VIVO (Meridian Bioscience) with a proven track record?
Which analyst has the current lower performing score on VIVO (Meridian Bioscience) with a proven track record?
Which analyst has the most public recommendations on VIVO (Meridian Bioscience)?
Which analyst is the currently most bullish on VIVO (Meridian Bioscience)?
Which analyst is the currently most reserved on VIVO (Meridian Bioscience)?